Cardiac MRI study of adverse events in patients treated with immune checkpoint inhibitors: a prospective cohort study of cardiac adverse events

Immune checkpoint inhibitors (ICIs) revolutionized cancer therapy, yet require management of immune-related adverse events (irAEs). Fulminant myocarditis is a rare irAE, but lower-severity cardiac events are being reported more frequently, leading to an unmet need for irAE prevention, early diagnosi...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonio Di Muzio, Alessandro Marchese, Lorenzo Monti, Cristina Panico, Marinos Kallikourdis, Gianluigi Condorelli, Armando Santoro, Matteo Simonelli, Angelo Dipasquale, Pasquale Persico, Laura Giordano, Giovanna Finocchiaro, Agnese Losurdo, Matteo Perrino, Marco Francone, Chiara Catalano, Simone Serio, Federica Catapano, Stefano Figliozzi, Carla D’Andrea, Marco Cremonesi, Maria Chiara Tronconi, Enrico Lugli
Format: Article
Language:English
Published: BMJ Publishing Group 2025-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/3/e010568.full
Tags: Add Tag
No Tags, Be the first to tag this record!